Plain-English translation of NCT06399952 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study for people diagnosed with Baker Gordon Syndrome, a rare genetic condition that affects brain development. Researchers will track your health over time by collecting information about your development, learning, movement, sleep, and seizures. They'll also take small blood and skin samples to study how the genetic changes in this condition affect the brain, helping them understand the disease better and develop treatments in the future.
Baker Gordon Syndrome is a newly recognized rare genetic disorder, and doctors still have much to learn about how it develops and what treatments might help. This study exists to gather detailed information about the condition so that scientists can identify patterns, understand what causes symptoms, and test potential therapies down the road.
You likely qualify if…
You likely don't qualify if…
You will work with the research team to share your medical history and records. During the study, you'll complete developmental and memory assessments, keep diaries of sleep and seizures if applicable, and have blood tests and brain imaging (MRI) done. You'll also provide a small skin sample that researchers will use to grow cells in the lab to study how the genetic mutation affects brain development. Your parent or caregiver will also participate by providing information and consent.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Sponsor
University of Missouri-Columbia
Enrollment target
~50 participants
Started
April 2024
Primary completion
May 2027
Age range
0 Years – 99 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
W. David R Arnold, MD
University of Missouri-Columbia
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.